Drugs of abuse are known to be a significant co-factor in HIV infection. However addressing whether drugs of abuse are significant co-factors in disease progression has been difficult. Methamphetamine (METH) is a frequently and increasingly used drug among those infected with HIV, and those at high risk for becoming HIV infected. Our Preliminary Data indicates that METH can negatively affect many parameters of simian immunodeficiency virus (SIV)-induced disease in monkeys. Here we proposed a well- powered study to obtain definitive results on the interaction of METH and SIV. Our hypothesis is that there are distinct areas of interaction occur between these agents that combine to increase disease. First, there is a combined toxic effect in the central nervous system (CNS), in which SIV and METH combine to yield functional and biochemical deficits both greater and different than either agent alone. Second, there is an interaction in the immune system that affects disease course and likely secondarily the CNS. Third, both SIV and METH affect autophagy, an essential process in neurons whose disruption leads to neuronal damage, and the effects of SIV and METH together are greater than either alone. Pharmacological agents that affect autophagy will be tested in a preclinical setting to provide both mechanistic insights and provide leads for treatment strategies. Those infected with HIV, and those at high risk for HIV infection, include people that frequently use drugs of abuse, including methamphetamine, the use of which is increasing nationwide. Methamphetamine can damage the brain, as can HIV infection. Here we will examine how these two agents interact to cause brain as well as other problems, and such work will provide insight into not only these two agents, but means to protect neurons from other damaging processes. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
7R01DA024467-02
Application #
7500678
Study Section
Special Emphasis Panel (ZDA1-NXR-B (20))
Program Officer
Lawrence, Diane M
Project Start
2007-09-30
Project End
2011-06-30
Budget Start
2008-09-15
Budget End
2009-06-30
Support Year
2
Fiscal Year
2008
Total Cost
$363,825
Indirect Cost
Name
University of Nebraska Medical Center
Department
Pharmacology
Type
Schools of Medicine
DUNS #
168559177
City
Omaha
State
NE
Country
United States
Zip Code
68198
Villeneuve, Lance M; Purnell, Phillip R; Stauch, Kelly L et al. (2016) HIV-1 transgenic rats display mitochondrial abnormalities consistent with abnormal energy generation and distribution. J Neurovirol 22:564-574
Jagadish, T; Pottiez, G; Fox, H S et al. (2012) Plasma gelsolin accumulates in macrophage nodules in brains of simian immunodeficiency virus infected rhesus macaques. J Neurovirol 18:113-9
Kritzik, Marcie R; Lago, Cory U; Kayali, Ayse G et al. (2010) Epithelial progenitor 1, a novel factor associated with epithelial cell growth and differentiation. Endocrine 37:312-21
Marcondes, Maria Cecilia Garibaldi; Flynn, Claudia; Watry, Debbie D et al. (2010) Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys. Am J Pathol 177:355-61
Alirezaei, Mehrdad; Fox, Howard S; Flynn, Claudia T et al. (2009) Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy 5:152-8
Coutinho, Alice; Flynn, Claudia; Burdo, Tricia H et al. (2008) Chronic methamphetamine induces structural changes in frontal cortex neurons and upregulates type I interferons. J Neuroimmune Pharmacol 3:241-5
Alirezaei, Mehrdad; Kiosses, William B; Flynn, Claudia T et al. (2008) Disruption of neuronal autophagy by infected microglia results in neurodegeneration. PLoS One 3:e2906
Alirezaei, Mehrdad; Kiosses, William B; Fox, Howard S (2008) Decreased neuronal autophagy in HIV dementia: a mechanism of indirect neurotoxicity. Autophagy 4:963-6